Provided by Tiger Trade Technology Pte. Ltd.

Enliven Treateutics

46.97
+0.76001.64%
Post-market: 46.970.00000.00%19:30 EDT
Volume:1.12M
Turnover:52.60M
Market Cap:3.44B
PE:-28.04
High:47.43
Open:47.38
Low:45.92
Close:46.21
52wk High:62.32
52wk Low:14.79
Shares:73.27M
Float Shares:61.73M
Volume Ratio:1.07
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6753
EPS(LYR):-1.8300
ROE:-15.31%
ROA:-11.00%
PB:3.84
PE(LYR):-25.67

Loading ...

Enliven Net Loss Widens 28.2% to $32.5 Million in Q2 FY26

Reuters
·
Aug 06

Enliven Therapeutics CMO Helen Louise Collins Disposes of USD 262,213 in Common Shares

Reuters
·
Jul 22

13D Filings

Dow Jones
·
Jul 11

Enliven price target raised to $65 from $56 at H.C. Wainwright

TIPRANKS
·
Jul 09

Enliven Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $64 from $56

THOMSON REUTERS
·
Jul 09

Enliven Therapeutics Director Lori Anne Kunkel Disposes of USD 504,256 Common Shares

Reuters
·
Jul 09

Orbimed Advisors Reports Enliven Therapeutics Common Stock Sale Worth $38.02 Million

Reuters
·
Jun 25

Enliven Therapeutics CMO Helen Louise Collins disposes of USD 217,816 in common shares

Reuters
·
Jun 23

OrbiMed Advisors reports $12.67 million Enliven Therapeutics common stock sale

Reuters
·
Jun 18

Enliven Therapeutics Closes Upsized $460 Million Public Offering

MT Newswires Live
·
Jun 16

Enliven Therapeutics closes upsized public offering, raises USD 460 million gross

Reuters
·
Jun 16

Jefferies Remains a Buy on Enliven Therapeutics (ELVN)

TIPRANKS
·
Jun 15

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Twist Bioscience (TWST)

TIPRANKS
·
Jun 15

Why Is Enliven Therapeutics Stock (ELVN) Up Today?

TIPRANKS
·
Jun 13

Enliven rises 9.9%

TIPRANKS
·
Jun 13

BUZZ-Enliven soars after boosted equity raise for leukemia drug

Reuters
·
Jun 12

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Ahead of SpaceX Debut

MT Newswires Live
·
Jun 12

Enliven Therapeutics Prices $400 Million Public Offering

MT Newswires Live
·
Jun 12

BRIEF-Enliven Therapeutics Prices 8.9 Million Shares At $37.50 Per Share

Reuters
·
Jun 12

Enliven Therapeutics prices upsized public offering at $37.5 per share, targets $400 million gross proceeds

Reuters
·
Jun 12